TCT 11: Five-year Follow-up of the First-in-Man Use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: A Serial Multi-Imaging Modality Study

Presenter: Patrick W. Serruys

REGISTER for free or LOG IN to view this content

TCT 11: Five-year Follow-up of the First-in-Man Use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: A Serial Multi-Imaging Modality Study

We Recommend